
Top stories

HealthcareCases of rubella spike countrywide while diphtheria hits Western Cape
Tamsin Metelerkamp 20 Dec 2024





More news











Marketing & Media
Chicken Licken bravely debones a rare phobia with their latest campaign
Joe Public 3 days



“The vaccine protects against the most virulent strain [of meningitis] in Africa that causes 85 percent of all damages and this vaccine will address much of the difficulty [of treatment],” said Professor Marc Laforce, head of the Meningitis Vaccine Project (MVP).
According to Laforce, clinical trials conducted in Senegal, The Gambia and Mali showed positive results. “The vaccine is very immunogenic”, he said.